A subset of liver resident natural killer cells is expanded in hepatitis C-infected patients with better liver function
暂无分享,去创建一个
A. Branch | T. Schiano | F. Eng | Adeeb H. Rahman | A. El-shamy | M. Fiel | S. Florman | C. Aloman | B. Haydel | Arielle L. Klepper | E. Doyle | A. Klepper | Arielle Klepper | M. Fiel
[1] A. Branch,et al. Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infection , 2019, PLoS pathogens.
[2] Dominic Grün,et al. A Human Liver Cell Atlas reveals Heterogeneity and Epithelial Progenitors , 2019, Nature.
[3] F. Locatelli,et al. Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation , 2019, Front. Immunol..
[4] P. Kamath,et al. Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013. , 2018, Gastroenterology.
[5] F. Ginhoux,et al. Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease. , 2017, Journal of hepatology.
[6] J. Strominger,et al. Transcriptome analysis reveals similarities between human blood CD3− CD56bright cells and mouse CD127+ innate lymphoid cells , 2017, Scientific Reports.
[7] L. Stein,et al. Reactome pathway analysis: a high-performance in-memory approach , 2017, BMC Bioinformatics.
[8] N. Sheikh,et al. How Does Interleukin-22 Mediate Liver Regeneration and Prevent Injury and Fibrosis? , 2016, Journal of immunology research.
[9] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[10] J. Geoghegan,et al. Tissue‐resident Eomeshi T‐betlo CD56bright NK cells with reduced proinflammatory potential are enriched in the adult human liver , 2016, European journal of immunology.
[11] B. Davidson,et al. CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver , 2016, Scientific Reports.
[12] G. Lauer,et al. Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver , 2014, PloS one.
[13] C. Brander,et al. HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans , 2014, Science Translational Medicine.
[14] Hui Wang,et al. The complex and central role of interferon‐γ in graft‐versus‐host disease and graft‐versus‐tumor activity , 2014, Immunological reviews.
[15] Sandra Romero-Steiner,et al. Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines , 2013, Nature Immunology.
[16] A. Mania,et al. Detection and Significance of Cytotoxic Cell Subsets in Biopsies of HCV-Infected Human Livers , 2013, Archivum Immunologiae et Therapiae Experimentalis.
[17] S. Gabriel,et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. , 2013, Gastroenterology.
[18] S. Ludovisi,et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection , 2012, Hepatology.
[19] A. Zignego,et al. Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact , 2012, Journal of Translational Medicine.
[20] S. Dooley,et al. Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. , 2012, Gastroenterology.
[21] K. Sherman,et al. HIV/hepatitis C coinfection natural history and disease progression. , 2011, Current opinion in HIV and AIDS.
[22] S. Dooley,et al. In vivo consequences of liver‐specific interleukin‐22 expression in mice: Implications for human liver disease progression , 2011, Hepatology.
[23] K. Mitchell,et al. Regulation of hepatocyte fate by interferon-γ. , 2011, Cytokine & growth factor reviews.
[24] Michael G Brown,et al. Intrahepatic IL-10 Maintains NKG2A+Ly49− Liver NK Cells in a Functionally Hyporesponsive State , 2010, The Journal of Immunology.
[25] J. Fung,et al. Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. , 2009, Journal of hepatology.
[26] Ben S. Wittner,et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.
[27] F. Ginhoux,et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis , 2009, Hepatology.
[28] Xuetao Cao,et al. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. , 2008, Blood.
[29] M. Caligiuri,et al. Human natural killer cells. , 2008, Blood.
[30] Eric Vivier,et al. Functions of natural killer cells , 2008, Nature Immunology.
[31] D. Adams,et al. Immune-mediated liver injury. , 2007, Seminars in liver disease.
[32] S. Friedman,et al. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. , 2006, Journal of Hepatology.
[33] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[34] A. Berrebi,et al. Human decidual NK cells: unique phenotype and functional properties -- a review. , 2006, Placenta.
[35] A. Lohse,et al. Immune-mediated liver injury. , 2005, Journal of hepatology.
[36] A. Thomson,et al. Low TLR4 Expression by Liver Dendritic Cells Correlates with Reduced Capacity to Activate Allogeneic T Cells in Response to Endotoxin1 , 2005, The Journal of Immunology.
[37] R. Sun,et al. Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.
[38] R. DeMatteo,et al. Liver Dendritic Cells Are Less Immunogenic Than Spleen Dendritic Cells because of Differences in Subtype Composition1 , 2004, The Journal of Immunology.
[39] J. Neuberger. Treatment of hepatitis C virus infection in the allograft , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[40] P. Park,et al. Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential , 2003, The Journal of experimental medicine.
[41] E. Nishida,et al. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway , 2002, Nature Cell Biology.
[42] A. Anel,et al. Granzymes are essential for natural killer cell‐mediated and perf‐facilitated tumor control , 2002, European journal of immunology.
[43] D. Doherty,et al. Innate and adaptive lymphoid cells in the human liver , 2000, Immunological reviews.
[44] D. Doherty,et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. , 1999, Journal of immunology.
[45] G. Trinchieri,et al. Human natural killer cells. , 1979, Transplantation proceedings.
[46] H. Kopcow,et al. Transcriptome analysis reveals similarities between human blood CD3 − CD56 bright cells and mouse CD127 + innate lymphoid cells , 2017 .
[47] S. Bicciato,et al. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. , 2016, Journal of autoimmunity.
[48] T. Strom,et al. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. , 2011, Gastroenterology.
[49] W. Jeong,et al. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. , 2008, Gastroenterology.
[50] I. N. Crispe,et al. Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.
[51] Sandra Romero-Steiner,et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .